Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
In Good Company: This ‘hidden gem’ offers escape from club chaos, KC’s corporate nightlife
A new East Crossroads venue on McGee offers no clues of what’s inside. The black facade out front features no marquee. No neon lights. It’s the first indication that In Good Company is something different from neighboring Power & Light District hot spots. The goal: Good people. Good drinks. Good vibes. “It’s not a club.…
Protein-packed pallets: Sam’s Club deal pushes SimplyFUEL balls to record production (and Mitzi Dulan is rolling with it)
Juggling more than 50 million protein balls in 2024 is paying off for SimplyFUEL, Mitzi Dulan said, noting production quadrupled during the past year after adding retail giant Sam’s Club to its wholesale lineup. The founder and CEO is already riding that momentum in 2025, she said, teasing another big retailer launch in April. It’s…
Kansas City HR tech startup earns $9M defense contract to help hire skilled workers for nuclear subs
Meeting the U.S. Navy’s aggressive hiring goals requires collaboration across thousands of contractors in all 50 states at a time when America is already experiencing a shortage of skilled workers, said Ray Dick, co-founder of a talent assessment and hiring software platform developed specifically for manufacturing and skilled trades. His Kansas City, Missouri-based company, Piccadilly…
Fifth & Emery rebrand puts local in control; Isaac Lee Collins’ next move: add handmade chocolate
Taking his businesses independent is the cherry on top for Isaac Lee Collins, following more than a decade building his credentials as one of Kansas City’s most consistent and resilient entrepreneurs. A rebrand of Collins’ frozen yogurt ventures adds a further twist to his story. “After 10 years of being a franchisee of Yogurtini and…